載入...
Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
INTRODUCTION. Immune checkpoint inhibitors (ICIs) have changed the oncologic landscape in the past few years. Alongside impressive antitumor responses, new novel immune‐related adverse events (irAEs) have emerged; pneumonitis is an irAE that can potentially be fatal and necessitates a proper managem...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516115/ https://ncbi.nlm.nih.gov/pubmed/30777894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0352 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|